Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen

Nature Reviews Rheumatology 13, 136 (2017). doi:10.1038/nrrheum.2017.4 Author: Michael T. Nurmohamed The PRECISION trial demonstrates that celecoxib is noninferior to ibuprofen and naproxen in regard to cardiovascular safety. Do these findings mark the end of the debate on this issue, or do aspects of the trial mean the implications for clinical practice are not clear-cut?
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Tags: News and Views Source Type: research